Conclusions and Relevance In this meta-analysis of randomized clinical trials, a genotype-guided dosing strategy did not result in a greater percentage of time that the INR was within the therapeutic range, fewer patients with an INR greater than 4, or a reduction in major bleeding or thromboembolic events compared with clinical dosing algorithms.
Wednesday, October 29, 2014
Genotype based warfarin dosing
The latest meta-analysis:
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment